FDA Seeks Answers As Testosterone Lawsuits Mount Against 'Low T' Drug Makers
The FDA Is Seeking Input From Its Advisory Panels As Testosterone Lawsuits Mount And Reports That Low Testosterone Medication Purportedly Cause Heart Attacks And Strokes Reports Wright & Schulte LLC Columbus, OH (PRWEB) August 10, 2014 As Testosterone Lawsuits claims continue to be filed in a industry-wide consolidation, Wright & Shulte LLC reports the U.S. Food & Drug Administration (FDA) has called for a meeting to be held on September 17 for two of its advisory panels to weigh in on the potential risks for testosterone replacement therapy drugs such as AndroGel, Androderm, a
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Categories
- Articles 313
- Bankruptcy 44
- Business 135
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 57
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 609
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4